Critical illness neuromuscular disease: Clinical electrophysiological, and prognostic aspects

Archives of Disease in Childhood

Volumn 86, Issue 2, 2002, Pages 103-107

  Tabarki, B ^a   Coffinieres A ^b   Van den Bergh, P ^a   Huault, G ^b   Landrieu, P ^b   Sebire G ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AZATHIOPRINE; CEFTAZIDIME; CHLORPROMAZINE; CIPROFLOXACIN; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN; DEXAMETHASONE; DOPAMINE; FENTANYL; FLUNITRAZEPAM; METHYLPREDNISOLONE; MIDAZOLAM; MUSCLE RELAXANT AGENT; ORNIDAZOLE; PREDNISONE; PROMETHAZINE; SALBUTAMOL; VANCOMYCIN; VECURONIUM;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASTHMATIC STATE; BONE MARROW APLASIA; BONE MARROW TRANSPLANTATION; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONVULSION; CRITICAL ILLNESS; ELECTROPHYSIOLOGY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR DISEASE; PARALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEPTIC SHOCK; VIRUS HEPATITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FATAL OUTCOME; FEMALE; HUMANS; MALE; NEURAL CONDUCTION; NEUROMUSCULAR DISEASES; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROGNOSIS; RETROSPECTIVE STUDIES; VECURONIUM BROMIDE;

EID: 0036165785     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.86.2.103     Document Type: Article

References (36)

1. Critical illness polyneuropathy
2. Neuromuscular complications of sepsis
3. The neurological complications of sepsis
4. Peripheral nerve function in sepsis and multiple organ failure
5. Critically ill patients with newly acquired weakness: The clinicopathological spectrum
6. Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects
7. Polyneuropathie au cours de séjours prolongés en réanimation
8. Neuropathies toxiques
9. Severe myopathy after status asthmaticus
10. Muscle weakness in mechanically ventilated patients with severe asthma
11. Acute quadriplegic myopathy: A complication of treatment with steroids, non depolarising blocking agents or both
12. Acute type II myofiber atrophy in critical illness
13. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids
14. Prolonged paralysis due to non depolarising neuromuscular blocking agents and corticosteroids
15. Persistent paralysis in critically ill patients after long-term administration of vecuronium
16. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents
17. A syndrome of acute severe muscle necrosis in intensive care unit patients
18. Neuromuscular complications of sepsis in children
19. Critical illness neuromuscular disease in children manifested as ventilatory dependence
20. Critical illness polyneuropathy in a two years old girl with hemorragic shock encephalopathy syndrome
21. Peripheral neuropathy and neuromuscular blockage presenting as prolonged respiratory paralysis following critical illness
22. Critical illness polyneuropathy in adolescence
23. Critical illness neuropathy in pediatric intensive care patients
24. Acute steroid-induced tetraplegia following status asthmaticus
25. Poliomyelitis-like paralysis during recovery from acute bronchial asthma: Possible etiology and risk factors
26. Prolonged myasthenic syndrome after one week of muscle relaxants
27. Muscle weakness and atrophy following prolonged paralysis with pancuronium bromide in neonates
28. Skeletal muscle growth failure induced in premature newborn infants by prolonged pancuronium
29. Prolonged neuromuscular blockade in an infant
30. Prolonged weakness after extended mechanical ventilation in a child
31. Outcome of pediatric patients with multiple organ system failure
32. Polyneuropathy complicating bone marrow transplantation and solid organ transplantation
33. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
34. Arthrogryposis following treatment of maternel tetanus with muscle relaxants
35. Pancuronium bromide induced joint contractures in the newborn
36. Monitoring neuromuscular function in the intensive care unit